New York Attorney General Letitia James today announced an historic proposed $26 billion agreement that will help deliver desperately needed relief to communities across New York and the rest of the nation struggling with opioid addiction. The proposed agreement will resolve claims against three of the nation’s largest drug distributors — McKesson Corporation, Cardinal Health Inc., and Amerisource Bergen Drug Corporation — as well as one of the nation’s largest drug manufacturers — Johnson & Johnson (J&J) — over the companies’ roles in creating and fueling the opioid epidemic. New York communities ravaged by opioids will specifically receive up to $1.25 billion to fund prevention, treatment, and recovery programs (the terms of New York’s specific settlements were previously announced with both the three distributors and with J&J). Additionally, today’s proposed agreement requires significant industry changes that aim to end the opioid epidemic and prevent this type of crisis from occurring again.
David Aden2021-06-21T19:24:57-04:00June 19th, 2021|
Journalists have largely presented the overdose crisis as a story of three interconnected and perhaps inevitable waves. First, drug companies, led by Purdue Pharma, maker of the notorious OxyContin, convinced gullible doctors to prescribe unneeded opioids.
The second wave in this narrative begins around 2011, when states cracked down on “pain clinics” that were really pill mills, offering doses for dollars.
Finally, the third wave was initiated by dealers about four years later. Seeing a chance to make even more money, they began to cut heroin with illicitly manufactured fentanyl and various other synthetic opioids, which are both cheaper to make and more potent.
SUBSCRIBE DONATE NOW Search Posts and/or Pages DONATE NOW Date: | Contributor: Source: ( ) | Category: Summary and Analysis... An apparent conclusion to the Federal prosecution of the Sackler family company for its part in bringing on the opioid crisis. This does not, however, end litigation for the Sacklers. According to the article "about 2,800 cities, counties, Native American tribes and other
SUBSCRIBE DONATE NOW Search Posts and/or Pages DONATE NOW Benzodiazepine prescriptions reach ‘disturbing’ levels in the US Date: | Contributor: Source: New Scientist (1/17/2020) | Category: Summary and Analysis... This article reports on a disconcerting trend -- a high level of benzodiazepine prescription in the US and abroad. In too many cases, the benzodiazepine's were co-prescribed with opioids even though the combination of the two can be
SUBSCRIBE DONATE NOW Search Posts and/or Pages DONATE NOW Pharmaceutical Executive Sentenced To 66 Months In Prison In Opioid Trial Date: | Contributor: Source: NPR (1/23/20) | Category: Summary and Analysis... The sentencing of a former pharmaceutical executive to more than five years in prison is being hailed as a potentially important warning to other pharmaceutical executives. Although this trial will hopefully signal the start of other
SUBSCRIBE DONATE NOW Search Posts and/or Pages DONATE NOW Purdue Pharma’s Foreign Affiliate Now Selling Overdose Cure Date: | Contributor: Source: WGBH (12/15/2019) | Category: Summary and Analysis... This article covers the history of Purdue Pharma playing both ends of the problem -- providing opioids that lead to addition and other drugs for those who become addicted. This serves as a cautionary tale for communities considering drug-based
SUBSCRIBE DONATE NOW Search Posts and/or Pages DONATE NOW FDA Warning Against False MAT Advertising Date: | Contributor: Source: U.S. Food and Drug Administration (12/11/2019) | Category: Summary and Analysis... This article covers the latest in a long history of misrepresentations by the industry about opioid-related drugs. It is well known that the pharmaceutical industry contributed materially to the current opioid crisis and has routinely engaged in
David Aden2021-06-21T19:23:26-04:00November 27th, 2019|
SUBSCRIBE DONATE NOW Search Posts and/or Pages DONATE NOW PhRMA ends funding for high-profile addiction treatment group Date: | Contributor: Source: Politico (11/25/19) | Category: Summary and Analysis... The Addiction Policy Forum, a non-profit which has been the subject of some concern because of its financial ties to the pharmaceutical industry, is now losing that support. For background on the concern, see Big Pharma Co-Opts Anti-Addiction Advocate. This